Drugs / Fecal microbiota material
Fecal microbiota material
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT05248191 Comparator | Apr 2022 → Dec 2023 | Crohn disease | University of Minnesota | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fecal microbiota material | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05248191 ↗ |
| Known as | cap-FMT | “Capsule fecal microbiota material (cap-FMT)” NCT05248191 ↗ |
| Known as | colo-FMT | “Colonoscopic fecal microbiota material (colo-FMT)” NCT05248191 ↗ |
| Route | Oral | “receive cap-FMT orally” NCT05248191 ↗ |